Adar1 Capital Management, LLC Inmune Bio, Inc. Put Options Transaction History
Adar1 Capital Management, LLC
- $652 Billion
- Q2 2025
Put Options
1 transactions
Others Institutions Holding INMB
# of Institutions
99Shares Held
6.31MCall Options Held
1.63MPut Options Held
3.34M-
Vanguard Group Inc Valley Forge, PA848KShares$1.81 Million0.0% of portfolio
-
Black Rock Inc. New York, NY813KShares$1.73 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$1.27 Million45.87% of portfolio
-
Ubs Group Ag449KShares$956,8400.0% of portfolio
-
Geode Capital Management, LLC Boston, MA390KShares$830,5530.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $38.2M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...